Home›Stock Screener›Mukka Proteins

Mukka Proteins Share Price Today | Stock Price & Mukka Proteins Share Screener

MUKKA Food Products
Live Share Price NSE
₹31.39
▼ -0.78 (-2.42%)
2026-09-15 00:00:00
Live Share Price BSE
₹24.85
▼ -0.38 (-1.51%)
2026-11-19 00:00:00

As of September 15, 2026, the live Mukka Proteins share price (NSE: MUKKA) is ₹31.39 on NSE and ₹24.85 on BSE, down 2.42% from the previous close, with shares trading between ₹30.95 and ₹33.29 in today's trading session, and a 52-week range of ₹18.49–₹32.17. Track MUKKA market cap trends to gauge the company's total market size. Use the Mukka Proteins stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Mukka Proteins opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹504 and net income of ₹18, with EBITDA of ₹37, an operating margin of 6.0% and a profit margin of 3.6%.

Mukka Proteins Market Cap ₹779.10 Cr.
MUKKA P/E Ratio (TTM) 9.10
Mukka Proteins P/B Ratio 1.44
EPS (TTM) ₹1.74
Dividend Yield -
Debt to Equity 1.31
MUKKA 52 Week High ₹32.17
Mukka Proteins 52 Week Low ₹18.49
Operating Margin 6.00%
Profit Margin 3.57%
MUKKA Revenue (TTM) ₹504.00
EBITDA ₹37.00
Net Income ₹18.00
Total Assets ₹1,621.00
Total Equity ₹529.00

Mukka Proteins Share Price Chart

Track the current stock price of Mukka Proteins with an interactive chart. Analyse MUKKA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Mukka Proteins stock quote in one place.

The quote of ₹31.39 sits between the 52-week low of ₹18.49 and the 52-week high of ₹32.17, and the latest session moved -2.42% from the previous close.

Mukka Proteins Company Profile - Fundamental Screener

Screen Mukka Proteins company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MUKKA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the FMCG sector and the Food Products industry, and it trades under ISIN INE0CG401037.

Company Details

Classification

Sector FMCG
Industry Food Products
Sub-Sector Food Products
Segment E

Identifiers and Leadership

ISIN INE0CG401037

Mukka Proteins Balance Sheet Screener

Screen MUKKA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,621, up from ₹1,076 in 2025.

Latest statistics put total assets at ₹1,621 and shareholder funds at ₹529, with a leverage ratio of 1.31.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 1,621 1,076 941 575 392 355 293 201
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 194 94 85 85 83 79 78 49

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 43 9 12 17 15 13 18 20
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 529 457 408 156 103 70 58 44
Share Capital 30 30 30 22 22 6 6 6
Reserves & Surplus 469 411 366 126 76 61 51 39

Mukka Proteins Income Statement Screener - Profit & Revenue Analysis

Screen Mukka Proteins income statement and profit fundamentals. Analyze MUKKA quarterly results. Mukka Proteins reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹504 and net profit was ₹18, equal to earnings per unit of ₹0.53, at an operating margin of 6%.

In that period expenses were ₹468, interest cost ₹17 and tax ₹10. The next period listed, 2026-Jun, shows revenue of ₹476 and net profit of ₹19.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 504 476 383 642 242 167 376 303 149 170 255 510 331 269 409
Expenses 468 443 347 608 224 157 353 262 140 159 225 498 294 260 378

Operating Costs and Margins

EBITDA 37 34 37 34 18 11 24 41 9 11 30 12 37 9 31
Operating Profit % 6.00% 7.00% 6.00% 4.00% 5.00% 5.00% 5.00% 12.00% 4.00% 5.00% 10.00% 1.00% 9.00% 2.00% 8.00%
Depreciation 6 5 5 4 4 3 3 4 4 3 3 3 3 3 3
Interest 17 17 15 15 13 11 10 11 9 8 7 6 6 6 7

Profit and Earnings

Profit Before Tax 27 27 29 35 9 2 20 33 1 6 27 18 35 8 33
Tax 10 9 8 7 2 1 6 6 0 0 -2 5 6 4 11
Net Profit 18 19 21 27 7 2 14 27 2 5 29 12 29 4 22
EPS 0.53 0.63 0.69 0.79 0.20 0.05 0.45 0.88 0.07 0.14 1.20 0.48 1.29 0.16 0.99

Mukka Proteins Cash Flow Screener - Liquidity Fundamentals

Screen MUKKA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹111, and net cash flow was an inflow of ₹10.

Over the same period, investing activities used ₹146 and financing activities provided ₹267.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities -111 -112 -150 -56 5 2 -25 -20
Investing Activities -146 -35 -48 -3 -12 -14 -28 -23

Financing and Net Cash

Financing Activities 267 56 266 75 15 14 54 34
Net Cash Flow 10 -91 68 15 8 2 1 -9

Mukka Proteins Shareholding Pattern Screener

See Mukka Proteins shareholding pattern with promoter, FII, and DII holdings. Check Mukka Proteins promoter holding and ownership changes for MUKKA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 73.33%, foreign institutions 1.70%, domestic institutions 0.20% and the public 23.21%, spread across 124,299 shareholders.

The shareholder count was 124,299 in 2026-Sept, compared with 127,922 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 73.33% 73.33% 73.33% 73.33% 73.33% 73.33% 73.33% 73.33%

Institutional Investors

FII Holding 1.70% 1.73% 1.70% 1.70% 1.70% 2.08% 2.63% 2.63%
DII Holding 0.20% 0.00% 0.00% 0.17% 1.66% 1.87% 1.98% 1.98%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.21% 23.49% 23.71% 23.67% 22.18% 21.55% 19.85% 19.43%
Other Holding 1.56% 1.44% 1.26% 1.14% 1.13% 1.15% 2.21% 2.62%
Shareholder Count 124,299 127,922 132,098 137,920 141,649 145,343 147,308 146,062

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Mukka Proteins. Mukka Proteins dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Mukka Proteins.

Mukka Proteins Stock Index Membership - Nifty & Sensex

See which indices include Mukka Proteins stock. Check MUKKA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE INDEX BSEFMC.

Among the benchmarks tracked are BSE INDEX BSEFMC, BSE INDEX SMLCAP, NIFTY IPO.

Complete Index List

BSE INDEX BSEFMC
BSE INDEX SMLCAP
NIFTY IPO

Mukka Proteins Market Events Screener - Corporate Actions

Get Mukka Proteins corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Mukka Proteins stock events that may affect MUKKA share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 7, 2026, with a record date of November 7, 2026.

It is followed by Annual General Meeting dated September 10, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-07 2026-11-07 Quarterly Result Announcement NA 11.22%
2026-09-10 2026-09-10 Annual General Meeting NA 14.37%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 2.99%
2026-05-15 2026-05-15 Quarterly Result Announcement NA -0.70%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 2.08%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -3.56%
2025-09-18 2025-09-18 Annual General Meeting NA -0.47%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.37%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 4.79%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -6.93%
2024-11-16 2024-11-16 Extraordinary General Meeting NA -0.98%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -11.65%
2024-09-26 2024-09-26 Annual General Meeting NA -14.00%

Mukka Proteins Competitors Screener - Peer Stocks Comparison

Screen MUKKA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the FMCG sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Nestle 249,582 61.20 23,195 14.48% 3,499 54.75
Britannia Industries 113,208 42.70 19,376 6.64% 2,537 43.66
Hatsun Agro Product 23,108 63.30 8,719 8.81% 279 46.17
Milky Mist Dairy Food 23,099 100.90 3,145 33.56% 127 51.94
Zydus Wellness 14,647 60.30 3,967 45.73% 197 39.90
Bikaji Foods International 12,262 48.80 3,045 14.96% 254 51.57
Manorama Industries 11,854 41.80 1,377 73.92% 225 47.09
Godrej Agrovet 11,144 25.40 10,339 9.68% 445 41.61
Kwality Walls 9,943 -40.10 0 0.00% -2 62.16
Avanti Feeds 9,915 20.20 6,277 8.89% 656 51.98

Mukka Proteins Company Announcements - News & Reports Screener

Screen MUKKA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2026.

The next most recent announcements are dated November 13, 2026 and November 11, 2026.

Date Update Actions
2026-11-14 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-11 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-11 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-11-11 Financial Results For The Quarter And Half Year Ended 30Th September 2026. -
2026-11-11 Intimation Of Statement Of Deviation And Variation -
2026-11-11 Board Meeting Outcome for Intimation Of Outcome Of Board Meeting -
2026-11-02 Board Meeting Intimation for Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended 30Th September 2026 -
2026-10-27 Intimation Of US FDA Registration. -
2026-10-09 Intimation Of Commencement Of Commercial Production By Overseas Subsidiary. -
2026-10-09 Intimation Of Giving Corporate Guarantee And Security By The Company. -
2026-10-07 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-10-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-06 Intimation Of Receipt Of USDA NOP - Inputs Attestation. -
2026-09-30 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-09-25 Closure of Trading Window -
2026-09-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-22 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹31.39, within a 52-week range of ₹18.49 to ₹32.17. The P/E ratio is 9.10 and the P/B ratio is 1.44, with earnings per unit of ₹1.74. Market capitalisation stands at ₹779.10 Cr. The company operates in the FMCG sector, in the Food Products industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.